Swift Technology Transfer Could Cut Years off Drug Development Timelines

Today the process is largely manual, but that is changing. The invention, rapid manufacturing and distribution of the COVID-19 vaccine demonstrates exactly how fast the life sciences treatment development pipeline can move when the right factors are in play. Biopharmaceutical treatments commonly take upwards of 15 years to develop, but the COVID vaccine was created and manufactured in only eight months.

Emerson’s President of the Process Systems and Solutions business Nathan Pettus shares his thoughts in this article in IndustryWeek magazine on how having the right technology, open standards and operational buy-in can reduce the technology transfer process to a fraction of the time it takes today.

Latest News

Emerson Ventures Invests in Symmera

Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...

Emerson Ventures Invests in First Resonance

Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System

Emerson Ventures Makes Strategic Investment in Spearix

Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
Please enable JavaScript to use this website.